Concord Biotech board to meet for Q2, half-year results

Concord Biotech Limited has scheduled a board of directors meeting for Thursday, November 13, 2025. The primary agenda includes the consideration and approval of the standalone and consolidated unaudited financial results for the second quarter and half-year ended September 30, 2025. This meeting will also address the limited review report to be issued by the statutory auditors and other business matters.

The announcement, dated November 8, 2025, was issued by hina patel, company secretary and compliance officer. The company's registered office and plant are located at 1482-1486, trasad road, dholka, dist. ahmedabad-382225.

Concord Biotech reiterated the closure of its trading window under SEBI (prohibition of insider trading) regulations, 2015. The trading window will remain closed for designated persons and their immediate relatives until 48 hours after the declaration of the financial results for the second quarter and half-year ended September 30, 2025.